AHPA: Citing Regulations In Form 483s Would Boost GMP Compliance
This article was originally published in The Tan Sheet
Executive Summary
FDA investigators should cite specific regulations related to each good manufacturing practice violation uncovered during an inspection to increase transparency, understanding and compliance, the American Herbal Products Association argues in a citizen petition. Other trade groups agree it is a good idea, but NPA doubts it will boost compliance, which falls on industry before an inspection.
You may also be interested in...
Compliance Data Should Be Linked To Enforcement Results – FDA Task Force
FDA’s transparency task force proposes a multi-pronged approach to make the agency’s compliance and enforcement data more accessible and user-friendly online.
J&J Consumer Sales Slip Even As Recalled Brands, Seasonal Items Reach Stores
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.
Ensuring Leading Position For GSK Consumer Products Touted In Management Shift
GlaxoSmithKline restructures its management to ensure adequate focus on its three core areas, pharmaceutical, vaccine and consumer. Consumer product sales fell 3% to $1.72 billion in the third quarter due to continuing supply interruptions and generally weaker markets.